KDR and Ewing sarcoma: Recently, Englisch et al. suggested that VEGFR-2 expressed on tumor vasculature could be a potential CAR target in Ewing sarcoma (EwS) (89), especially that this type of cancer is characterized by a limited TSA expression on cancer cells (90).